Thursday, April 24, 2014 12:11:56 PM
You can't compare the BAT deal SP move to the potential MSA SP move. They are Two Completely different scenarios. I came on board right after Sabby and I can tell you they were cashing out like there was no tomorrow. Sabby was a vampire on the XXII stock late last year.
IMO, a short squeeze will send us above .50 and 1. There would be little reason to short the stock right after MSA when we can expect distribution agreements (waiting for the green light) to be released.
Hedgies are sitting on us for to extract pennies while we wait for the MSA.
IMO, a short squeeze will send us above .50 and 1. There would be little reason to short the stock right after MSA when we can expect distribution agreements (waiting for the green light) to be released.
Hedgies are sitting on us for to extract pennies while we wait for the MSA.
Recent XXII News
- 22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership • GlobeNewswire Inc. • 04/29/2026 08:35:00 PM
- 22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University • GlobeNewswire Inc. • 04/23/2026 11:50:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/13/2026 04:15:24 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:35:13 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:30:36 PM
- 22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/31/2026 09:00:54 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/27/2026 08:30:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 12:02:51 PM
- 22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/26/2026 10:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/24/2026 05:57:09 PM
- 22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026 • GlobeNewswire Inc. • 03/23/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 09:14:20 PM
- 22nd Century Group Reports Continued Early Sales Momentum for VLN® Cigarette Products • GlobeNewswire Inc. • 02/23/2026 10:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 09:15:28 PM
- 22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/20/2026 09:15:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 04:59:02 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/13/2026 07:17:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 01:00:48 PM
- 22nd Century CEO & Chairman Larry Firestone Provides 2025 Year-in-Review Letter to Stockholders • GlobeNewswire Inc. • 01/15/2026 02:00:00 PM
- 22nd Century to Participate in the Needham Annual Growth Conference January 16, 2026 • GlobeNewswire Inc. • 01/12/2026 09:30:00 PM
- 22nd Century Files VLN® MRTP Renewal – Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less • GlobeNewswire Inc. • 01/06/2026 11:10:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/30/2025 10:19:44 PM
